Table 2.
Tracer indicators in respective domains of cancer services
| Domains | Tracer Items |
|---|---|
| Staff and guideline | Oncologists |
| Palliative care specialist | |
| Trained Nurse | |
| Guideline a | |
| Training a | |
| Equipment | Beds available for cancer patients |
| Speculum a | |
| Diagnostic facility | Acetic Acid a |
| Sputum for Cytology | |
| Stool occult blood test (OBT) | |
| Cancer antigen 15.3 (CA 15.3) | |
| Cancer antigen 19.9 (CA 19.9) | |
| Carcinoembryonic antigen (CEA) | |
| Cancer antigen 125 (CA125) | |
| Alpha Keto Protein | |
| Endoscopy of upper gastrointestinal tract | |
| Colonoscopy | |
| Pituitary tumor-transforming gene 1-binding factor (PBF) | |
| Bone Marrow Study | |
| Biopsy for Histopathology | |
| Fine Needle Aspiration Cytology (FNAC) | |
| Medicines | Hydrocortisone |
| Pheniramine | |
| Ondanseron | |
| Haloperidol | |
| Morphin injection | |
| Morphin tablet | |
| Lorazepam | |
| Hyoscine butylebromide | |
| Broad Spectrum Antibiotics | |
| Chemotherapeutic drugs |
a cervical cancer specific tracer items